SUMMARY Plasma levels of lipids, lipoprotein-cholesterol and three major apolipoproteins (ApoA-I, A-II and C-II) were studied in 318 black and white males and females randomly sampled in Evans County, Georgia. Black-white differences in lipid and lipoprotein-cholesterol concentrations were observed, with low-density fractions higher in whites and high-density fractions higher in blacks. Plasma levels of ApoA-I but not ApoA-II were higher in blacks than in whites and in females than in males. ApoC-II concentrations were lower in black than in white men and women.
THE RECENT REDISCOVERY of an inverse association between levels of plasma high-density lipoprotein (HDL) and coronary heart disease prevalence", 2 and incidence-" has renewed interest in factors that influence the balance between atherogenic low-density lipoproteins (LDL) and antiatherogenic HDL. 7 Female hormones,' 9 alcohol consumption'F03 and strenuous physical activity"'-" are associated with raised levels of HDL, while cigarette smoking"'0 17, 21 and obesity" [22] [23] [24] are associated with lower levels of HDL. Black children have higher levels of HDL than whites in the southern U.S.23 and in the urban North.26 HDL-cholesterol (HDL-C) is lower in coronary heart disease cases than in controls in both black and white males.27 Black residents of Evans County have a lower prevalence and incidence23 of coronary heart disease than white males. Black males in Evans County had a lower risk of coronary heart disease despite a markedly higher prevalence of hypertension in black than white males and persisted controlling for age, total serum cholesterol, smoking and blood pressure by logistic risk-function analysis. 29 The possibility that some of the lower risk of coronary heart disease in black males in Evans County was attributable to HDL-C was also suggested by the finding of significantly higher levels of HDL-C and significantly lower levels of very low density lipoprotein cholesterol (VLDL-C) and total plasma triglycerides in black than in white males, all free of coronary heart disease, controlling for levels of total plasma cholesterol. 23 Cholesterol represents only one of several chemical moieties in HDL, since HDL is composed of about 50% apoproteins and about 50% lipids. Apoproteins A-I and A-II (ApoA-I and ApoA-II) constitute about 90% of the mass of HDL protein, while ApoA-I and ApoA-II are present only in trace amounts of the other lipoprotein density fractions.30 Thus, ApoA-I and ApoA-II also represent valid indexes of plasma HDL levels. Apoliproprotein C-II (ApoC-II) serves a central role as a functional apoprotein in intravascular triglyceride metabolism as a modulator of the activity of lipoprotein lipase.31 832 In this study, we report on the distributions of these important apoproteins in a sample of the black and white residents of Evans County who were free of coronary heart disease.
Methods
Fasting plasma was drawn from an age-sexstratified random sample of all black and white survivors of the original 1960 Evans County cohort, free of coronary heart disease and residing in Evans County in 1977. This report is based on 82 white males, 68 black males, 95 
Results
The mean values of the major plasma lipids and of lipoprotein density fraction cholesterol stratified by race and sex are listed in table 1. Black and white examinees were sampled within age and sex strata and this is reflected in the similarity of the mean ages, ranging from 52.1-54.9 years, among the race-sex groups. As previously reported,23 blacks in the Evans County Heart Study had slightly lower total plasma cholesterol, but there were major differences in the distribution of cholesterol in the lipoprotein fractions; i.e., black men had significantly higher levels of HDL-C and lower levels of LDL-C than whites (table 1). In women the differences were similar to those for males, but of smaller magnitude and not statistically significantly different from zero. The mean values of ApoA-I, A-II and C-II are listed in table 2.
ApoA-I but not ApoA-II is significantly higher Having demonstrated the higher levels of ApoA-I, the association of ApoA-I and ApoA-II with HDL-C and with each other, the lower levels of ApoC-II in blacks than in whites, and the associations of ApoC-1I with VLDL and LDL lipids, the next set of analyses was directed to quantifying how much of the observed black-white differences in lipids was attributable statistically to the black-white differences in levels of apoproteins.
Covariance analysis was used to adjust the observed levels of lipids for the differences in apoproteins for each race-sex group and then to contrast the adjusted lipid values in blacks and whites (table 5) . Black-white differences in HDL-C in men were decreased from 10.7 mg/dl to 8.3 mg/dl after adjusting for ApoA-I, a 22% reduction; however, the residual difference of 8.3 mg/dl was still large and significant (p < 0.005). ApoA-II considered alone as a covariate did not reduce the black-white difference in HDL-C, nor did it contribute additionally to the effect of Apo-A when the sum of ApoA-I and ApoA-II was treated as a covariate.
The effect of controlling for the level of ApoC-II was to produce major decreases in black-white differences in LDL-C, total C, VLDL-C and triglyceride in males, such that none of the adjusted differences was significantly different from zero. None of the black-white lipid differences in women was significantly different from zero, although the triglyceride difference was large (-20.4 mg/dl). After controlling for ApoC-II the black-white triglyceride difference was reduced to -6.9 mg/dl, a 66% decrease.
Given that ApoC-II and triglyceride values are closely correlated in plasma, ApoC-II was then used as the dependent variable in the covariance model and 
Discussion
This community-based study has disclosed blackwhite differences in mean levels of ApoA-I and ApoC-II and statistical associations between levels of apoproteins and levels of plasma total cholesterol, triglycerides and lipoprotein cholesterol. The data also demonstrate black-white differences in levels of HDL-C that are not totally attributable statistically to differences in ApoA-I, suggesting that the HDL composition of blacks may be different from that of whites. Similarly, there are black-white differences in the atherogenic lipoprotein fractions (VLDL and LDL) that are statistically explainable (in the sense of association, not necessarily of causal process) by the differences in ApoC-II. However, residual, statistically unexplained differences in ApoC-II, adjusting for levels of lipoproteins, again suggested that there may be black-white differences in lipoprotein composition.
Obviously, any conclusions must be qualified by the fact that the measured levels of apoproteins, lipids and lipoprotein density fraction cholesterol represent single, one-time concentrations that result from an extremely large number of interacting biochemical and metabolic processes and that the associations reported are cross-sectional and statistical rather than the results of experimental perturbation produced in individuals. Nevertheless, the findings should stimulate more "'metabolically" oriented research to explain the black-white differences reported herein.
There were significant black-white differences in HDL-C, especially in men. However, only about onefifth of the black-white differences in HDL-C is attributable statistically to differences in levels of ApoA-I. In addition, there are suggestive differences in ApoA-I/ApoA-II ratios by race. This raises the possibility of black-white differences in compositional properties of HDL, e.g., differences in the relative proportions of HDL2 and HDLM. ApoA-I/ApoA-II ratios in women than in men, an expectation borne out by the data ( 
